By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Response Genetics said that it expects to close today a private placement of its common shares, through which the firm expects to raise $4 million.

The Los Angeles-based molecular diagnostics firm said that it has signed a purchase agreement with certain new and existing investors and funds managed by Landsdowne Partners. It expects to sell to those buyers 3,005,349 of newly issued common shares at a price of $1.31 per share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene regulation changes linked to human brain evolution, and more.

The New York Stem Cell Foundation's Initiative on Women in Science and Engineering working group presents seven strategies to promote gender equality in the sciences.

Researchers link a genetic variation to the ability to quickly process arsenic in people living in the Andes Mountains.

A small portion of pregnant women who've undergone non-invasive prenatal testing have found out from the test that they have cancer.